-
Denosumab is an antibody that blocks the RANK ligand, a protein that tells the body to remove bone.
FORBES: Amgen's Next Opponents
-
Macrocycles offer a number of advantages over bigger biologics, including better ligand efficiency, tissue penetration, delivery, and cost.
FORBES: Innovation Snapshot: Macrocyclic drugs to unlock new therapeutic targets
-
It turns out that in excess quantities, acetaminophen's breakdown products latch on to the FAS ligand of liver cells.
FORBES: Magazine Article
-
Cells have receptors on their surface that, when the right key (or ligand) is inserted, cause them to change.
FORBES: Magazine Article
-
"I don't think we're going to find the magic bullet--but we're going to get closer, " says Andres Negro-Vilar, chief scientific officer at Ligand Pharmaceuticals.
FORBES: Silencing "Syndrome X"
-
In osteoporosis the RANK ligand protein is all too effective in producing the breakdown effect, resulting in debilitating hip fractures in postmenopausal women and others.
FORBES: Biotech Behemoth
-
The drug is a bioengineered antibody to a crucial natural protein called Rank-ligand that appears to play a central role in initiating the bone breakdown process.
FORBES: Breaking Merck's Bones
-
Behan, a native of Liverpool, England with a doctorate in biochemistry, believed he could come up with drug candidates without knowing the ligand part of the equation.
FORBES: The Next Fat Pill
-
Upon ligand engagement, these receptors in turn engage MyD88 which signals through IRAK4 to turn on a variety of pathways, including NF-kB and the secretion of pro-inflammatory cytokines.
FORBES: Immunokinase Drug Candidates: $12B in Value Creation and Counting
-
In the last two years the instruments have been employed in deals proposed by Sanofi-Aventis ( NYSE:SNY), AstraZeneca ( NYSE:AZN) and Ligand Pharmaceuticals ( Nasdaq:LGND), among many others.
FORBES: Shadowy Shares: The Dark Side of Contingent Value Rights
-
Drugmakers looked for proteins called ligands, which dock to specific GPCRs, and then created a drug that either blocked or enhanced the ability of the ligand to connect with its receptor.
FORBES: The Next Fat Pill